Roche Pharmaceutical Development and Sales Overview

YTD Sep 2022: Diagnostics Division regional sales Growth driven by Asia Pacific and North America Sales YTD CHFm & % of total sales Total YTD Sales = 13,848 Sales growth at CER Diagnostics Division 6% GLOBAL 808 -13% EMEA* 6% 20% NAM 4,595 / 28% APAC 33% -3% LATAM 4,522 / 33% 3,923/ 28% EMEA* ■NAM APAC ■ LATAM CER-Constant Exchange Rates (avg. full year 2021); * Europe, Middle East and Africa Roche 170

View entire presentation